Accendra Health Affirms FY2026 Sales Guidance of $2.550B-$2.650B vs $2.590B Est

Benzinga Newsdesk www.benzinga.com Negative 77.4%

Neg 77.4% Neu 0% Pos 0%

Accendra Health (NYSE:ACH) affirms FY2026 sales outlook from $2.550 billion-$2.650 billion to $2.550 billion-$2.650 billion vs $2.590 billion estimate.